Literature DB >> 21547520

Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis.

Johanna Schneider1, Achim Lother, Lutz Hein, Ralf Gilsbach.   

Abstract

Increased activity of the sympathetic system is an important feature contributing to the pathogenesis and progression of chronic heart failure. While the mechanisms and consequences of enhanced norepinephrine release from sympathetic nerves have been intensely studied, the role of the adrenal gland in the development of cardiac hypertrophy and progression of heart failure is less well known. Thus, the aim of the present study was to determine the effect of chronic cardiac pressure overload in mice on adrenal medulla structure and function. Cardiac hypertrophy was induced in wild-type mice by transverse aortic constriction (TAC) for 8 weeks. After TAC, the degree of cardiac hypertrophy correlated significantly with adrenal weight and adrenal catecholamine storage. In the medulla, TAC caused an increase in chromaffin cell size but did not result in chromaffin cell proliferation. Ablation of chromaffin α(2C)-adrenoceptors did not affect adrenal weight or epinephrine synthesis. However, unilateral denervation of the adrenal gland completely prevented adrenal hypertrophy and increased catecholamine synthesis. Transcriptome analysis of microdissected adrenal medulla identified 483 up- and 231 downregulated, well-annotated genes after TAC. Among these genes, G protein-coupled receptor kinases 2 (Grk2) and 6 and phenylethanolamine N-methyltransferase (Pnmt) were significantly upregulated by TAC. In vitro, acetylcholine-induced Pnmt and Grk2 expression as well as enhanced epinephrine content was prevented by inhibition of nicotinic acetylcholine receptors and Ca(2+)/calmodulin-dependent signaling. Thus, activation of preganglionic sympathetic nerves innervating the adrenal medulla plays an essential role in inducing adrenal hypertrophy, enhanced catecholamine synthesis and induction of Grk2 expression after cardiac pressure overload.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547520     DOI: 10.1007/s00395-011-0166-z

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  14 in total

Review 1.  Alpha2-adrenoceptors in adrenomedullary chromaffin cells: functional role and pathophysiological implications.

Authors:  Antonio R Artalejo; Luis Alcides Olivos-Oré
Journal:  Pflugers Arch       Date:  2017-08-23       Impact factor: 3.657

Review 2.  Are the pharmacology and physiology of α₂ adrenoceptors determined by α₂-heteroreceptors and autoreceptors respectively?

Authors:  Ralf Gilsbach; Lutz Hein
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 3.  Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair.

Authors:  Jordana I Borges; Krysten E Ferraino; Natalie Cora; Deepika Nagliya; Malka S Suster; Alexandra M Carbone; Anastasios Lymperopoulos
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

4.  Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy.

Authors:  Asli F Ceylan-Isik; Maolong Dong; Yingmei Zhang; Feng Dong; Subat Turdi; Sreejayan Nair; Masashi Yanagisawa; Jun Ren
Journal:  Basic Res Cardiol       Date:  2013-02-05       Impact factor: 17.165

5.  Exploration of cardiometabolic and developmental significance of angiotensinogen expression by cells expressing the leptin receptor or agouti-related peptide.

Authors:  Sarah A Sapouckey; Lisa L Morselli; Guorui Deng; Chetan N Patil; Kirthikaa Balapattabi; Vanessa Oliveira; Kristin E Claflin; Javier Gomez; Nicole A Pearson; Matthew J Potthoff; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-03-18       Impact factor: 3.619

6.  Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.

Authors:  Fadia A Kamal; Deanne M Mickelsen; Katherine M Wegman; Joshua G Travers; Jacob Moalem; Stephen R Hammes; Alan V Smrcka; Burns C Blaxall
Journal:  J Am Coll Cardiol       Date:  2014-04-02       Impact factor: 24.094

7.  GRK2 Up-Regulation Creates a Positive Feedback Loop for Catecholamine Production in Chromaffin Cells.

Authors:  Malika Jafferjee; Thairy Reyes Valero; Christine Marrero; Katie A McCrink; Ava Brill; Anastasios Lymperopoulos
Journal:  Mol Endocrinol       Date:  2016-02-05

8.  Effect of heart failure on catecholamine granule morphology and storage in chromaffin cells.

Authors:  Sushil K Mahata; Hong Zheng; Sumana Mahata; Xuefei Liu; Kaushik P Patel
Journal:  J Endocrinol       Date:  2016-07-08       Impact factor: 4.286

9.  Sanggenon C protects against pressure overload‑induced cardiac hypertrophy via the calcineurin/NFAT2 pathway.

Authors:  Lili Xiao; Yulei Gu; Lu Gao; Jiahong Shangguan; Yang Chen; Yanzhou Zhang; Ling Li
Journal:  Mol Med Rep       Date:  2017-08-18       Impact factor: 2.952

Review 10.  Adrenal adrenoceptors in heart failure.

Authors:  Claudio de Lucia; Grazia D Femminella; Giuseppina Gambino; Gennaro Pagano; Elena Allocca; Carlo Rengo; Candida Silvestri; Dario Leosco; Nicola Ferrara; Giuseppe Rengo
Journal:  Front Physiol       Date:  2014-07-07       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.